Error: Could not add to watchlist. X
+ Watchlist

NextCell Pharma AB

NEXTCL:SS
AktieTorget
Pending Listing
NEXTCL:SS is pending listing
SEK
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (-) (TTM)
-
Market Cap (SEK)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
NextCell Pharma AB operates as a tissue establishment and primary biobank. The Company develops novel treatments with stem cells from the umbilical cord. NextCell Pharma focuses on developing treatments for therapeutic immunomodulation of autoimmune and inflammatory diseases including for transplantation applications.
Address
Karolinska Institutet Science
Halsovagen 7
Huddinge, 141 57
Sweden
Phone
46-8-735-20-10
  • Mathias Svahn
    CEO/Co-Founder
  • Edvard Smith
    Dir:Medical/Co-Founder
  • Anders Essen-Moller
    Dir:Business Development
  • Lotten Lofberg
    Dir:Commercial
Show More